12:07 PM EST - PanGenomic Health Inc : Announces that further to its news release of September 1, 2022, it has entered into a definitive share exchange agreement dated November 18, 2022 with Mydecine Innovations Group Inc., a company listed on the NEO Exchange, and Mydecine's wholly owned subsidiary, Mindleap Health Inc., to acquire all of the issued and outstanding shares of Mindleap. Mindleap launched the world's first telehealth platform for psychedelic integration on the iOS and Android stores in 2020. PanGenomic Health Inc
shares C.NARA are trading unchanged at $0.19.
